Thalidomide: all 323 studies that test it
Page 4 of 4. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00006016Phase 2
- Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically RemovedCompletedNCT00006006Phase 2
- Thalidomide in Treating Patients With Gynecologic SarcomasCompletedNCT00006005Phase 2
- Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00005966Phase 3
- S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple MyelomaTerminatedNCT00005834Phase 3
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
- Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial CancerCompletedNCT00004876Phase 2
- Randomized Study of Beta Interferon and Thalidomide in Patients With AdrenoleukodystrophyCompletedNCT00004450Not applicable
- Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV InfectionsCompletedNCT00004276Phase 2
- Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow TransplantCompletedNCT00003894Phase 2
- Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00003850Phase 2
- Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood CancersCompletedNCT00003754Phase 2
- A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAARTCompletedNCT00002392Not applicable
- Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected PatientsCompletedNCT00002174Not applicable
- Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting SyndromeCompletedNCT00002157Not applicable
- A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting SyndromeCompletedNCT00002127Phase 2
- Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIVCompletedNCT00002104Phase 1
- A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus ErythematosusCompletedNCT00001680Phase 2
- Pilot Study of Thalidomide to Treat Sjogren's SyndromeCompletedNCT00001599Phase 2
- Thalidomide to Treat Oral Lesions in HIV-Infected PatientsCompletedNCT00001524Phase 2
- A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerCompletedNCT00001446Phase 2
- A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 InfectionCompletedNCT00000812Phase 1
- Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV InfectionCompletedNCT00000790Phase 2